These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 657182)

  • 1. Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.
    Neugebauer G
    Cardiovasc Res; 1978 Apr; 12(4):247-54. PubMed ID: 657182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effects of the slow intravenous infusion of verapamil].
    de Moura RS
    Arq Bras Cardiol; 1982 Feb; 38(2):111-4. PubMed ID: 7159243
    [No Abstract]   [Full Text] [Related]  

  • 3. Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.
    Singh BN; Chew CY; Josephson MA; Packer M
    Am J Cardiol; 1982 Oct; 50(4):886-93. PubMed ID: 6751064
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog.
    Satoh K; Yanagisawa T; Taira N
    J Cardiovasc Pharmacol; 1980; 2(3):309-18. PubMed ID: 6156328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nifedipine on coronary and systemic hemodynamics in the conscious dog.
    Gross R; Kirchheim H; von Olshausen K
    Arzneimittelforschung; 1979; 29(9):1361-8. PubMed ID: 42417
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular effects of dimethophrine in the dog].
    Monguzzi G; Romano A; Scrollini F
    G Ital Cardiol; 1973; 3(1):102-11. PubMed ID: 4695015
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of myocardial reactive hyperaemia but not of hypoxic coronary vasodilatation by constant verapamil infusion in the in situ dog heart.
    Koller A; Rubányi G; Ligeti L; Kovách AG
    Acta Physiol Acad Sci Hung; 1982; 59(2):187-95. PubMed ID: 7158373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic serum concentration: an effect blocked by verapamil.
    Bittar G; Friedman HS; Dominguez A; Vorperian V
    J Pharmacol Exp Ther; 1991 Apr; 257(1):214-8. PubMed ID: 2019987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552).
    Basu DK; Brahmankar DM
    Mater Med Pol; 1985; 17(2):103-6. PubMed ID: 4079466
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
    Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa: its effect on the cardiovascular system.
    Carrasco HA; Lozano J; Lang TW; Meerbaum S
    Geriatrics; 1971 Sep; 26(9):100-8. PubMed ID: 5125691
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
    Ro YM; Markle DR; Goldstein SR; Speir E; Greene R; Steadman K; Aamodt R; Epstein SE; Patterson RE
    J Pharmacol Exp Ther; 1989 Feb; 248(2):654-60. PubMed ID: 2918474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil and nitroglycerin on coronary and systemic hemodynamics in conscious dogs.
    Adachi H; Tomoike H; Nishijima H; Hayashi Y; Yamada A; Nakamura M
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1072-8. PubMed ID: 3110406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil.
    Ruedy J
    Clin Invest Med; 1981; 4(2):129-47. PubMed ID: 7026099
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of verapamil on coronary hemodynamics in patients with coronary heart disease.
    Simonsen S
    Eur J Cardiol; 1978 Aug; 8(1):9-18. PubMed ID: 689073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of verapamil on the normal and ischemic heart].
    Furuya Y; Yokoyama S; Morimoto S; Nagara M; Tanaka S; Fujita M
    Masui; 1983 Apr; 32(4):409-17. PubMed ID: 6887505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.